Herpes zoster is associated with herpes simplex and other infections in under 60 year-olds

Journal of Infection

Volumn 70, Issue 2, 2015, Pages 171-177

  Ogunjimi, Benson ^a,b   Buntinx, Frank ^c,d   Bartholomeeusen, Stephaan ^c   Terpstra, Ita ^a   De haes, Inke ^a   Willem, Lander ^a   Elli, Steven ^c   Bilcke, Joke ^a   Van Damme, Pierre ^a   Coenen, Samuel ^a   Beutels, Philippe ^a,e  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b HASSELT UNIVERSITY   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Herpes simplex; Herpes zoster; Influenza; Susceptibility

Indexed keywords

CORTICOSTEROID;

ADULT; ARTICLE; ASTHMA; AUTOIMMUNE DISEASE; BELGIUM; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FRACTURE; HERPES SIMPLEX; HERPES ZOSTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEOPLASM; RETROSPECTIVE STUDY; RISK FACTOR; VACCINATION; CASE CONTROL STUDY; COMPLICATION; MIDDLE AGED;

CASE-CONTROL STUDIES; FEMALE; HERPES SIMPLEX; HERPES ZOSTER; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 84921064923     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2014.08.016     Document Type: Article

References (54)

1. Dolin R., Reichman R.C., Mazur M.H., Whitley R.J. NIH conference. Herpes zoster-varicella infections in immunosuppressed patients. Ann Intern Med 1978 Sep, 89(3):375-388.
2. Buntinx F., Bartholomeeusen S., Belmans A., Mathei C., Opdenakker G., Sweldens K., et al. Association between recent herpes zoster but not herpes simplex infection and subsequent risk of malignancy in women: a retrospective cohort study. Epidemiol Infect 2013 Aug 2, 1-10.
3. Levin M.J., Smith J.G., Kaufhold R.M., Barber D., Hayward A.R., Chan C.Y., et al. Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine. J Infect Dis 2003 Nov 1, 188(9):1336-1344. Epub 2003/11/01.
4. Ogunjimi B., Smits E., Hens N., Hens A., Lenders K., Ieven M., et al. Exploring the impact of exposure to primary varicella in children on varicella-zoster virus immunity of parents. Viral Immunol 2011 Apr, 24(2):151-157. Epub 2011/04/01.
5. Bilcke J., Ogunjimi B., Marais C., de Smet F., Callens M., Callaert K., et al. The health and economic burden of chickenpox and herpes zoster in Belgium. Epidemiol Infect 2012 Nov, 140(11):2096-2109.
6. Guess H.A., Broughton D.D., Melton L.J., Kurland L.T. Epidemiology of herpes zoster in children and adolescents: a population-based study. Pediatrics 1985 Oct, 76(4):512-517.
7. Terada K., Kawano S., Yoshihiro K., Morita T. Varicella-zoster virus (VZV) reactivation is related to the low response of VZV-specific immunity after chickenpox in infancy. J Infect Dis 1994 Mar, 169(3):650-652.
8. Levin M.J., Oxman M.N., Zhang J.H., Johnson G.R., Stanley H., Hayward A.R., et al. Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine. JInfect Dis 2008 Mar 15, 197(6):825-835.
9. Arvin A.M., Koropchak C.M., Wittek A.E. Immunological evidence of reinfection with varicella-zoster virus. J Infect Dis 1983, 148(2):200-205.
10. Vossen M.T., Gent M.R., Weel J.F., de Jong M.D., van Lier R.A., Kuijpers T.W. Development of virus-specific CD4+ T cells on reexposure to Varicella-Zoster virus. J Infect Dis 2004 Jul 1, 190(1):72-82.
11. Ogunjimi B., Smits E., Heynderickx S., Van den Bergh J., Bilcke J., Jansens H., et al. Influence of frequent infectious exposures on general and varicella-zoster virus-specific immune responses in pediatricians. Clin Vaccine Immunol 2014 Mar, 21(3):417-426.
12. Hope-Simpson R.E. The nature of herpes zoster: a Long-Term Study and a new hypothesis. Proc R Soc Med 1965 Jan, 58:9-20. Epub 1965/01/01.
13. Thomas S.L., Wheeler J.G., Hall A.J. Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study. Lancet 2002 Aug 31, 360(9334):678-682. Epub 2002/09/21.
14. Ogunjimi B., Van Damme P., Beutels P. Herpes zoster risk reduction through exposure to chickenpox patients: a systematic multidisciplinary review. PLoS One 2013, 8(6):e66485.
15. Opstelten W., Van Essen G.A., Schellevis F., Verheij T.J., Moons K.G. Gender as an independent risk factor for herpes zoster: a population-based prospective study. Ann Epidemiol 2006 Sep, 16(9):692-695.
16. Schmader K., George L.K., Burchett B.M., Pieper C.F., Hamilton J.D. Racial differences in the occurrence of herpes zoster. J Infect Dis 1995 Mar, 171(3):701-704.
17. Thomas S.L., Wheeler J.G., Hall A.J. Case-control study of the effect of mechanical trauma on the risk of herpes zoster. BMJ 2004 Feb 21, 328(7437):439.
18. Arndt V., Vine M.F., Weigle K. Environmental chemical exposures and risk of herpes zoster. Environ Health Perspect 1999 Oct, 107(10):835-841.
19. Schmader K., Studenski S., MacMillan J., Grufferman S., Cohen H.J. Are stressful life events risk factors for herpes zoster?. J Am Geriatr Soc 1990 Nov, 38(11):1188-1194.
20. Lasserre A., Blaizeau F., Gorwood P., Bloch K., Chauvin P., Liard F., et al. Herpes zoster: family history and psychological stress-case-control study. J Clin Virol 2012 Oct, 55(2):153-157.
21. Irwin M., Costlow C., Williams H., Artin K.H., Chan C.Y., Stinson D.L., et al. Cellular immunity to varicella-zoster virus in patients with major depression. J Infect Dis 1998 Nov, 178(Suppl. 1):S104-S108.
22. Irwin M.R., Levin M.J., Laudenslager M.L., Olmstead R., Lucko A., Lang N., et al. Varicella zoster virus-specific immune responses to a herpes zoster vaccine in elderly recipients with major depression and the impact of antidepressant medications. Clin Infect Dis 2013 Apr, 56(8):1085-1093.
23. Heymann A.D., Chodick G., Karpati T., Kamer L., Kremer E., Green M.S., et al. Diabetes as a risk factor for herpes zoster infection: results of a population-based study in Israel. Infection 2008 Jun, 36(3):226-230.
24. Kahl L.E. Herpes zoster infections in systemic lupus erythematosus: risk factors and outcome. J Rheumatol 1994 Jan, 21(1):84-86.
25. Kim B.S., Mehra S., Yawn B., Grose C., Tarrell R., Lahr B., et al. Increased risk of herpes zoster in children with asthma: a population-based case-control study. J Pediatr 2013 Sep, 163(3):816-821.
26. Gupta G., Lautenbach E., Lewis J.D. Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2006 Dec, 4(12):1483-1490.
27. Smitten A.L., Choi H.K., Hochberg M.C., Suissa S., Simon T.A., Testa M.A., et al. The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom. Arthritis Rheum 2007 Dec 15, 57(8):1431-1438.
28. Mullooly J.P., Riedlinger K., Chun C., Weinmann S., Houston H. Incidence of herpes zoster, 1997-2002. Epidemiol Infect 2005 Apr, 133(2):245-253.
29. Strangfeld A., Listing J., Herzer P., Liebhaber A., Rockwitz K., Richter C., et al. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents. JAMA 2009 Feb 18, 301(7):737-744.
30. Antoniou T., Zheng H., Singh S., Juurlink D.N., Mamdani M.M., Gomes T. Statins and the risk of herpes zoster: a population-based cohort study. Clin Infect Dis 2014 Feb, 58(3):350-356.
31. Thomas S.L., Wheeler J.G., Hall A.J. Micronutrient intake and the risk of herpes zoster: a case-control study. Int J Epidemiol 2006 Apr, 35(2):307-314.
32. Chen J.Y., Chu C.C., Lin Y.S., So E.C., Shieh J.P., Hu M.L. Nutrient deficiencies as a risk factor in Taiwanese patients with postherpetic neuralgia. Br J Nutr 2011 Sep, 106(5):700-707.
33. Thomas S.L., Hall A.J. What does epidemiology tell us about risk factors for herpes zoster?. Lancet Infect Dis 2004 Jan, 4(1):26-33.
34. Zak-Prelich M., Borkowski J.L., Alexander F., Norval M. The role of solar ultraviolet irradiation in zoster. Epidemiol Infect 2002 Dec, 129(3):593-597.
35. Spruance S.L., Kriesel J.D., Evans T.G., McKeough M.B. Susceptibility to herpes labialis following multiple experimental exposures to ultraviolet radiation. Antiviral Res 1995 Sep, 28(1):57-67.
36. Hernandez P.O., Javed S., Mendoza N., Lapolla W., Hicks L.D., Tyring S.K. Family history and herpes zoster risk in the era of shingles vaccination. J Clin Virol 2011 Dec, 52(4):344-348.
37. Haanpää M., Nurmikko T., Hurme M. Polymorphism of the IL-10 gene is associated with susceptibility to herpes zoster. Scand J Infect Dis 2002, 34(2):112-114.
38. Bochud P.Y., Magaret A.S., Koelle D.M., Aderem A., Wald A. Polymorphisms in TLR2 are associated with increased viral shedding and lesional rate in patients with genital herpes simplex virus Type 2 infection. J Infect Dis 2007 Aug 15, 196(4):505-509.
39. Lekstrom-Himes J.A., Hohman P., Warren T., Wald A., Nam J.M., Simonis T., et al. Association of major histocompatibility complex determinants with the development of symptomatic and asymptomatic genital herpes simplex virus type 2 infections. JInfect Dis 1999 May, 179(5):1077-1085.
40. Stowe R.P., Peek M.K., Cutchin M.P., Goodwin J.S. Reactivation of herpes simplex virus type 1 is associated with cytomegalovirus and age. J Med Virol 2012 Nov, 84(11):1797-1802. Epub 2012/09/22.
41. Ogunjimi B., Theeten H., Hens N., Beutels P. Serology indicates cytomegalovirus infection is associated with varicella-zoster virus reactivation. J Med Virol 2014 May, 86(5):812-819.
42. Okkes I.M., Becker H.W., Bernstein R.M., Lamberts H. The March 2002 update of the electronic version of ICPC-2. A step forward to the use of ICD-10 as a nomenclature and a terminology for ICPC-2. Fam Pract 2002 Oct, 19(5):543-546.
43. Methodology. WCCfDS. ATC/DDD Index 2010.
44. Ozawa A., Sasao Y., Iwashita K., Miyahara M., Sugai J., Iizuka M., et al. HLA-A33 and -B44 and susceptibility to postherpetic neuralgia (PHN). Tissue Antigens 1999 Apr, 53(3):263-268.
45. Sato M., Ohashi J., Tsuchiya N., Kashiwase K., Ishikawa Y., Arita H., et al. Association of HLA-A*3303-B*4403-DRB1*1302 haplotype, but not of TNFA promoter and NKp30 polymorphism, with postherpetic neuralgia (PHN) in the Japanese population. Genes Immun 2002 Dec, 3(8):477-481. Epub 2002/12/18.
46. Chiu C., McCausland M., Sidney J., Duh F.M., Rouphael N., Mehta A., et al. Broadly reactive human CD8 T cells that recognize an epitope conserved between VZV, HSV and EBV. PLoS Pathog 2014 Mar, 10(3):e1004008.
47. Cho J.W., Shin D.H., Lee K.S. Polymorphism of the IL-10 gene is associated with susceptibility to herpes zoster in Korea. J Dermatol Sci 2007 Mar, 45(3):213-215.
48. Kriesel J.D., Jones B.B., Matsunami N., Patel M.K., St Pierre C.A., Kurt-Jones E.A., et al. C21orf91 genotypes correlate with herpes simplex labialis (cold sore) frequency: description of a cold sore susceptibility gene. J Infect Dis 2011 Dec 1, 204(11):1654-1662.
49. Oxman M.N., Levin M.J., Johnson G.R., Schmader K.E., Straus S.E., Gelb L.D., et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005 Jun 2, 352(22):2271-2284.
50. Levin M.J., Schmader K.E., Gnann J.W., McNeil S.A., Vesikari T., Betts R.F., et al. Varicella-zoster virus-specific antibody responses in 50-59-year-old recipients of zoster vaccine. JInfect Dis 2013 Nov 1, 208(9):1386-1390.
51. Chlibek R., Bayas J.M., Collins H., de la Pinta M.L., Ledent E., Mols J.F., et al. Safety and immunogenicity of an AS01-adjuvanted varicella-zoster virus subunit candidate vaccine against herpes zoster in adults >=50 years of age. J Infect Dis 2013 Dec 15, 208(12):1953-1961.
52. Burgoon M.P., Cohrs R.J., Bennett J.L., Anderson S.W., Ritchie A.M., Cepok S., et al. Varicella zoster virus is not a disease-relevant antigen in multiple sclerosis. Ann Neurol 2009 Apr, 65(4):474-479.
53. Sotelo J., Ordonez G., Pineda B., Flores J. The participation of varicella zoster virus in relapses of multiple sclerosis. Clin Neurol Neurosurg 2014 Apr, 119:44-48.
54. Leung J., Harpaz R., Molinari N.A., Jumaan A., Zhou F.J. Herpes zoster incidence among insured persons in the United States, 1993-2006: evaluation of impact of varicella vaccination. Clin Infect Dis 2011 Feb 1, 52(3):332-340.